IMMUNAI
AstraZeneca is investing $18 million in Immunai Inc to use AI to improve the efficiency of cancer drug trials.
Popular Posts

Heidi Luo is an intern reporter at Blue Tech Wave specialising in IT and tech trends. She graduated from Cardiff University. Send tips to h.luo@btw.media